Aries Wealth Management’s Axsome Therapeutics AXSM Stock Holding History

Aries Wealth Management’s Portfolio AXSM Stock Details AXSM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$979K	Hold	4,000	–	–	0.19%	101
2026 Q1	$676K	Hold	4,000	–	–	0.15%	121
2025 Q4	$731K	Hold	4,000	–	–	0.16%	117
2025 Q3	$486K	Hold	4,000	–	–	0.11%	145
2025 Q2	$418K	Hold	4,000	–	–	0.11%	156
2025 Q1	$467K	Hold	4,000	–	–	0.13%	144
2024 Q4	$338K	Hold	4,000	–	–	0.09%	170
2024 Q3	$359K	Hold	4,000	–	–	0.1%	167
2024 Q2	$322K	Hold	4,000	–	–	0.1%	155
2024 Q1	$319K	Hold	4,000	–	–	0.1%	159
2023 Q4	$318K	Hold	4,000	–	–	0.11%	147
2023 Q3	$268K	Hold	4,000	–	–	0.1%	162
2023 Q2	$287K	Hold	4,000	–	–	0.11%	154
2023 Q1	$247K	Hold	4,000	–	–	0.1%	166
2022 Q4	$309K	Buy	+4,000	New	+$239K	0.13%	144

Other funds holding AXSM

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Aries Wealth Management's AXSM Position: Q2 2026 in Review

Aries Wealth Management held its Axsome Therapeutics (AXSM) position steady in Q2 2026 at 4,000 shares worth $979K. The position accounts for 0.19% of the portfolio, ranked #101.

Aries Wealth Management first reported a position in AXSM in Q4 2022 and has held it in 15 quarters since. 506 funds tracked by Wall St. Rank hold AXSM as of Q2 2026.

Aries Wealth Management held 4,000 shares of Axsome Therapeutics worth $979K as of Q2 2026.
Aries Wealth Management left its Axsome Therapeutics share count unchanged in Q2 2026.
Axsome Therapeutics made up 0.19% of Aries Wealth Management's portfolio in Q2 2026, its #101 holding.
Aries Wealth Management first reported a position in Axsome Therapeutics in Q4 2022 and has held it in 15 quarters since.
506 funds tracked by Wall St. Rank held Axsome Therapeutics as of Q2 2026.

Based on Aries Wealth Management's 13F filing for Q2 2026, filed 24 Jul 2026.